Page 76 - IJB-10-2
P. 76

International Journal of Bioprinting                                         Advancements in 3D printing




            bioinks are then used in 3D printing to construct organs   developmental studies. Abate’s team introduced a novel
            or organ prototypes. This approach finds extensive utility   microfluidic technique named high-resolution single-cell
            in tissue repair, which is instrumental for unraveling tissue   printing.  This technique utilizes a highly miniaturized
                                                                      140
            development mechanisms and facilitating drug screening.   microfluidic sorter within Bioprine to precisely print
            Hydrogels, formulated from hydrophilic polymers such as   individual cells from a mixture of multiple candidates.
            alginate, gelatin, and GelMA, undergo crosslinking through   Achieving precision at ~10 μm and a speed of ~100 Hz,
            various mechanisms, such as thermal entanglement,   this  approach  has  notable  implications for  bioprinting
            molecular self-assembly, electrostatic interactions, ionic   applications requiring single-cell precision.
            bonding, and chemical reactions. Cui et al. introduced
            an innovative technique  employing  3D  cell  printing   This technology overcame the limitations of traditional
            technology to establish a method for addressing volumetric   tissue engineering methods with low spatial resolution
                                     135
            muscle loss using dECM bioink.  This technique facilitated   and allows for precise control of cell distribution. In the
            the generation of volumetric muscle structures utilizing   “cell printing” process, cells (or cell aggregates) and a sol
            cell-loaded dECM bioinks with the aid of a particle-  gel (precursor of hydrogel) are simultaneously placed
            based printing approach. The outcomes underscore the   in the printhead of a printer. The deposition positions
            potential of 3D cell printing in conjunction with tissue-  of cell-containing droplets are controlled by a computer,
            derived bioinks for effectively generating biomimetic   and printing is done point by point at specified locations.
            engineered muscles, thus enhancing the treatment of   After printing one layer, another layer is printed on top,
            volumetric muscle loss injuries. Proposed by Ribezzi et al.,   and  this layer-by-layer  process  continues  to create  a  3D
            a groundbreaking approach termed embedded extrusion   multicellular/gel system.
            volume printing, which encompasses polymer extrusion   Compared to traditional tissue engineering techniques like
            bioprinting and layerless ultrafast volumetric bioprinting,   “cell-scaffold” methods, cell printing offers several advantages:
            allows for the spatial arrangement of various inks and cell   (i) simultaneous construction of biologically active 2D or
            types, opening up new avenues for producing biologically   3D “multi-cell/material” systems; (ii) accurate deposition of
            functional regenerative grafts.  Moreover, this approach   different types of cells in spatiotemporal manner; and (iii)
                                    136
            holds promise in developing engineered living systems and   creation of a 3D microenvironment for cells.
            models for metabolic diseases.
                                                                  Furthermore, cell printing is a high-throughput
               Ali et al. devised a kidney-specific microenvironment   cell arrangement technology that is entirely computer-
            for kidney tissue bioprinting using a photo-crosslinked   controlled and can be developed into a technique for in
            kidney ECM-derived bioink called KdECMMA.  The     situ operations within an organism. This technology finds
                                                     137
            resulting bioprinted kidney constructs exhibit both   applications in tissue engineering, development of cell-
            structural and functional traits akin to native kidney   based sensors, modeling in drug metabolism kinetics, and
            tissue. The utility of tissue-specific ECM-derived bioinks   drug screening (Figure 19).
            was demonstrated in cell-based bioprinting, promoting
            cell maturation and eventual tissue formation. Singh et   5. Discussion
            al.  utilized coaxial  3D cell  printing  technology to  craft
            microfluidic hollow tubes, comprising tubular/vascular   3D bioprinting technology can meet personalized, small-
            renal parenchyma composed of tubular epithelial cells   batch, and large-scale medical needs. It has been widely
            and endothelial cells.  They developed a hybrid bioink   used in the field of in vitro medical device manufacturing
                             138
            that can create the microenvironment of vascularized   and is currently being extended to personalized permanent
            native kidney tissue. With rapid crosslinking properties,   implants, clinical prosthetics, and drug development
            this  hybrid  bioink  optimizes  cell  function  and  retains   trials. However, with the expansion of the application of
            the predefined hollow tube architecture, which holds   3D  bioprinting  technology  in  the  field  of  biomedicine,
            promise for applications in regenerative medicine. On the   problems such as low printing throughput, standardization
            other hand, Kim et al. innovatively modified the 3D cell   of preparations, and specialization have become key
            printing  process  to  yield  in situ  uniaxial  alignment  and   constraints restricting the application of this technology.
            microtopography.   Leveraging  3D  printing  technology,   In addition to adopting the core technology of traditional
                          139
            they successfully generated cell-based dECM structures   3D printing, all manufacturing processes must be able
            imbued with distinct topographical cues. This approach’s   to satisfy biological and medical standards, as well as
            potential extension to various musculoskeletal tissues like   preserve cell activity and tissue function. This required
            tendons and ligaments could lead to the development of   extensive experimentations to optimize the integration of
            in vitro tissue-on-a-chip models for drug screening and   biomaterials, cells, and growth factors for 3D bioprinting


            Volume 10 Issue 2 (2024)                        68                                doi: 10.36922/ijb.1752
   71   72   73   74   75   76   77   78   79   80   81